Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajo Hamer

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Der Nervenarzt|September 12, 2019
[New classification of epileptic seizures : A critical evaluation of the changes]Andreas Schulze-Bonhage, Hajo Hamer, Günter Krämer
Seizure|January 7, 2016
Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOMHajo Hamer, Michel Baulac, Rob McMurray, et al.
Epilepsy & Behavior : E&B|February 26, 2021
Physical and mental health comorbidities of patients with epilepsy in Germany - A retrospective cohort studyPeter Uepping, Hajo Hamer, Jerome Scholten, et al.
Acta Neurologica Belgica|March 7, 2019
Lacosamide in patients with intellectual disability and refractory epilepsyAnika Kleist, Frank Kerling, Hajo Hamer, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|December 15, 2025
The impact of resective epilepsy surgery on cognitive estimation in patients with mesial temporal lobe lesionsOlivia Seiler, Katrin Walther, Hajo Hamer, et al.
Acta Neurologica Scandinavica|April 29, 2021
Long-term effects of zonisamide in adult patients with intellectual disabilityKattrinna Eck, Christophe Rauch, Frank Kerling, et al.
German Medical Science : GMS E-Journal|September 5, 2015
Use of a German longitudinal prescription database (LRx) in pharmacoepidemiologyHartmut Richter, Silvia Dombrowski, Hajo Hamer, et al.
Epilepsia|February 4, 2026
SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment responseJohannes Lang, Mathias Linnerbauer, Jeanne Cuny, et al.
Fortschritte Der Neurologie-Psychiatrie|April 23, 2024
[Neurorehabilitation after epilepsy surgery in the temporal lobe in patients with specific neurocognitive risk profiles]Michael Schwarz, Annabell Sophie Badstübner, Karlotta Meyn, et al.
Epilepsy & Behavior : E&B|November 29, 2024
Development of a questionnaire to measure patient-relevant needs and benefits in the treatment of epilepsy (PBI-Epilepsy)Toni Maria Janke, Jeanne Cuny, Christine Blome, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Der Nervenarzt|September 12, 2019
[New classification of epileptic seizures : A critical evaluation of the changes]Andreas Schulze-Bonhage, Hajo Hamer, Günter Krämer
Seizure|January 7, 2016
Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOMHajo Hamer, Michel Baulac, Rob McMurray, et al.
Epilepsy & Behavior : E&B|February 26, 2021
Physical and mental health comorbidities of patients with epilepsy in Germany - A retrospective cohort studyPeter Uepping, Hajo Hamer, Jerome Scholten, et al.
Acta Neurologica Belgica|March 7, 2019
Lacosamide in patients with intellectual disability and refractory epilepsyAnika Kleist, Frank Kerling, Hajo Hamer, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|December 15, 2025
The impact of resective epilepsy surgery on cognitive estimation in patients with mesial temporal lobe lesionsOlivia Seiler, Katrin Walther, Hajo Hamer, et al.
Acta Neurologica Scandinavica|April 29, 2021
Long-term effects of zonisamide in adult patients with intellectual disabilityKattrinna Eck, Christophe Rauch, Frank Kerling, et al.
German Medical Science : GMS E-Journal|September 5, 2015
Use of a German longitudinal prescription database (LRx) in pharmacoepidemiologyHartmut Richter, Silvia Dombrowski, Hajo Hamer, et al.
Epilepsia|February 4, 2026
SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment responseJohannes Lang, Mathias Linnerbauer, Jeanne Cuny, et al.
Fortschritte Der Neurologie-Psychiatrie|April 23, 2024
[Neurorehabilitation after epilepsy surgery in the temporal lobe in patients with specific neurocognitive risk profiles]Michael Schwarz, Annabell Sophie Badstübner, Karlotta Meyn, et al.
Epilepsy & Behavior : E&B|November 29, 2024
Development of a questionnaire to measure patient-relevant needs and benefits in the treatment of epilepsy (PBI-Epilepsy)Toni Maria Janke, Jeanne Cuny, Christine Blome, et al.
Pageof 9